Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Recruiting 38 Active not recruiting 20 Not yet recruiting 18 Completed 8 Withdrawn 4 Unknown 3 Terminated 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 8 Magnetic Resonance Spectroscopy 7 Biopsy 5 Nivolumab 4 Capecitabine 4 Vincristine 3 Radiosurgery 3 Paclitaxel 3 Irinotecan 3 Fluorouracil 3 Everolimus 3 Docetaxel 3 Dexamethasone 3 Cyclophosphamide 3 Cisplatin 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 spartalizumab 2 pembrolizumab 2 lenvatinib 2 daratumumab 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Injections 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × cemiplimab × Clear all

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡